UBS Maintains Buy on Encompass Health, Raises Price Target to $87

UBS maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $80 to $87.

Benzinga · 01/10/2020 15:33

UBS maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $80 to $87.